Heike Wulff

Overview

Best Publications

• International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels

  Aguan D. Wei;George A. Gutman;Richard W Aldrich;K. George Chandy

  1179
  Citations

• Voltage-gated potassium channels as therapeutic targets

  Heike Wulff;Neil A. Castle;Luis A. Pardo

  866
  Citations

• Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: A potential immunosuppressant

  Heike Wulff;Mark J. Miller;Wolfram Hänsel;Stephan Grissmer

  755
  Citations

• Ion Channels in Innate and Adaptive Immunity

  Stefan Feske;Heike Wulff;Edward Y Skolnik

  652
  Citations

• Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

  Christine Beeton;Heike Wulff;Nathan E. Standifer;Philippe Azam

  631
  Citations

• International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels : potassium channels

  George A. Gutman;K. George Chandy;John P. Adelman;Jayashree Aiyar

  598
  Citations

• K+ channels as targets for specific immunomodulation.

  K. George Chandy;Heike Wulff;Christine Beeton;Michael Pennington

  560
  Citations

• The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS

  Heike Wulff;Peter A. Calabresi;Rameeza Allie;Sung Yun

  543
  Citations

• Up-regulation of the IKCa1 Potassium Channel during T-cell Activation MOLECULAR MECHANISM AND FUNCTIONAL CONSEQUENCES

  Sanjiv Ghanshani;Heike Wulff;Mark J. Miller;Heike Rohm

  513
  Citations

• Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis

  Christine Beeton;Heike Wulff;Jocelyne Barbaria;Olivier Clot-Faybesse

  432
  Citations

• A non-hallucinogenic psychedelic analogue with therapeutic potential

  Lindsay P. Cameron;Robert J. Tombari;Ju Lu;Alexander J. Pell

  420
  Citations

• Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases

  Christine Beeton;Michael W. Pennington;Heike Wulff;Satendra Singh

  332
  Citations

• Molecular Properties and Physiological Roles of Ion Channels in the Immune System

  Michael D. Cahalan;Heike Wulff;K. George Chandy

  328
  Citations

• Amyloid-β protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity

  Izumi Maezawa;Pavel I. Zimin;Heike Wulff;Lee-Way Jin

  309
  Citations

• Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for Restenosis

  Ralf Köhler;Heike Wulff;Ines Eichler;Marlene Kneifel

  292
  Citations

• Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a New Activator of KCa2 and KCa3.1 Potassium Channels, Potentiates the Endothelium-Derived Hyperpolarizing Factor Response and Lowers Blood Pressure

  Ananthakrishnan Sankaranarayanan;Girija Raman;Christoph Busch;Tim Schultz

  281
  Citations

• The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans

  Kazuyoshi Toyama;Heike Wulff;K. George Chandy;Philippe Azam

  281
  Citations

• Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension

  Sebastian Brähler;Anuradha Kaistha;Volker J. Schmidt;Stephanie E. Wölfle

  279
  Citations

• Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases

  Alexander Schmitz;Ananthakrishnan Sankaranarayanan;Philippe Azam;Kristina Schmidt-Lassen

  268
  Citations

• K+ Channel Expression during B Cell Differentiation: Implications for Immunomodulation and Autoimmunity

  Heike Wulff;Hans Günther Knaus;Michael Pennington;K. George Chandy

  261
  Citations